Trevogrumab
- Generic Name
- Trevogrumab
- Drug Type
- Biotech
- CAS Number
- 1429201-24-0
- Unique Ingredient Identifier
- 87T4327873
- Background
Trevogrumab is under investigation in clinical trial NCT02943239 (Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women and Healthy Adult Men).
Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women and Healthy Adult Men
- First Posted Date
- 2016-10-24
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 82
- Registration Number
- NCT02943239
Study of the Blood Concentrations of Two Formulations of REGN1033 in Healthy Subjects
- First Posted Date
- 2016-04-18
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Regeneron Pharmaceuticals
- Target Recruit Count
- 28
- Registration Number
- NCT02741739
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath